A Study of LIPO-5 and ALVAC-HIV (vCP1452) as Possible HIV Vaccines
Clinical trial NCT00076063 · COMPLETED
Trial details
- NCT number
- NCT00076063
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2004-03-01
- Enrollment
- 174
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.